Graphical presentation of distributions of risk in screening

Journal of Medical Screening

Volumn 12, Issue 3, 2005, Pages 155-160

  Morris, J K ^a   Wald, N J ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL; INHIBIN A; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ARTICLE; DIAGNOSTIC PROCEDURE; DISEASE MARKER; DOWN SYNDROME; FETUS ECHOGRAPHY; FREQUENCY ANALYSIS; HUMAN; MASS SCREENING; PRENATAL DIAGNOSIS; PROBABILITY; RISK FACTOR; SECOND TRIMESTER PREGNANCY; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; STATISTICAL DISTRIBUTION;

ALPHA-FETOPROTEINS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CONFIDENCE INTERVALS; DOWN SYNDROME; FEMALE; GENETIC MARKERS; HUMANS; MASS SCREENING; NORMAL DISTRIBUTION; PREGNANCY; PRENATAL DIAGNOSIS; RISK; RISK FACTORS; STATISTICS;

EID: 25144495988     PISSN: 09691413     EISSN: None     Source Type: Journal    
DOI: 10.1258/0969141054855283     Document Type: Article

References (5)

1. Wald NJ, Hackshaw AK. Advances in antenatal screening for Down's syndrome. Balliere's Clin Obstet Gynaecol 2000;14:563-58
2. Wald N. Down's syndrome In: Wald NJ, Leck I, eds. Antenatal and Neonatal Screening 2nd edn. Oxford: Oxford University Press, 2000;85-11
3. Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). Health Technol Assess 2003;7:1-77
4. Wald N, Rodeck C, Rudnicka A, Hackshaw A. Nuchal translucency and gestational age. Prenat Diagn 2004;24:150-3
5. Palomaki GE, Hill LE, Knight GJ, Haddow JE, Carpenter M. Second-trimester maternal serum alpha-fetoprotein levels in pregnancies associated with Gastroschisis and Omphalocele. Obstet Gynecol 1988;71:906-9